Scientific Sessions 2025  /  Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH  /  Finding Drugs to Repurpose for Groups 2 and 3 PH: Is There Hope?
Logo

American Heart Association

  45
  0

Final ID:

Finding Drugs to Repurpose for Groups 2 and 3 PH: Is There Hope?

  • Spiekerkoetter, Edda  ( Stanford University , Stanford , California , United States )
  • Toshner, Mark  ( University of Cambridge , Cambridge , United Kingdom )
  • Prins, Kurt  ( University of Minnesota , Minneapolis , Minnesota , United States )
    • Author Disclosures:
    Edda Spiekerkoetter: DO NOT have relevant financial relationships | Mark Toshner: No Answer | Kurt Prins: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Molecular Determinants of Vascular Remodeling in Group 3 PH

Karmouty-quintana Harry, Eghbali Mansoureh, Ruffenach Gregoire

Heterogeneity Among Preclinical Models of Group 2 or Group 3 PH: Myth or Reality?

Lai Yen Chun, Shimoda Larissa, Goncharova Elena

More abstracts from these authors:
Multiomic Profiling Provides Molecular Insight into the Dysfunctional Right Atrium

Prins Kurt, Kazmirczak Felipe

Mentor

Spiekerkoetter Edda

You have to be authorized to contact abstract author. Please, Login
Not Available